MOLLY FRAGIACOMO: Open Payments
NPI 1952185258 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 61 payments from 16 companies in 2025. Trend: 2023 $92 · 2024 $1,847 · 2025 $1,149
Food & beverage: $1,149
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $261 |
| Axsome Therapeutics, Inc. | 13 | $218 |
| Tris Pharma Inc | 9 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| Neurocrine BioSciences, Inc. | 3 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Alkermes, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
Products named: VRAYLAR, Auvelity, Dyanavel XR, TRINTELLIX, INGREZZA, CAPLYTA, REXULTI, LYBALVI.
Industry payments across FL — which companies pay providers there.
